Exencial Wealth Advisors LLC Sells 172 Shares of Stryker Corporation $SYK

Exencial Wealth Advisors LLC lowered its stake in shares of Stryker Corporation (NYSE:SYK) by 2.5% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 6,575 shares of the medical technology company’s stock after selling 172 shares during the period. Exencial Wealth Advisors LLC’s holdings in Stryker were worth $2,601,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in SYK. Mid American Wealth Advisory Group Inc. bought a new position in Stryker during the second quarter worth about $26,000. Sachetta LLC boosted its holdings in Stryker by 58.7% during the second quarter. Sachetta LLC now owns 73 shares of the medical technology company’s stock worth $29,000 after buying an additional 27 shares during the last quarter. Goodman Advisory Group LLC bought a new position in shares of Stryker during the 1st quarter valued at about $32,000. Ridgewood Investments LLC lifted its holdings in shares of Stryker by 48.4% during the 2nd quarter. Ridgewood Investments LLC now owns 92 shares of the medical technology company’s stock valued at $36,000 after purchasing an additional 30 shares in the last quarter. Finally, Ransom Advisory Ltd bought a new position in shares of Stryker during the 1st quarter valued at about $37,000. Institutional investors own 77.09% of the company’s stock.

Analyst Ratings Changes

SYK has been the topic of several recent analyst reports. Evercore ISI cut their price objective on Stryker from $418.00 to $410.00 and set an “outperform” rating on the stock in a report on Tuesday, October 7th. Truist Financial cut their price objective on Stryker from $415.00 to $407.00 and set a “hold” rating on the stock in a report on Wednesday, October 15th. Weiss Ratings reiterated a “buy (b-)” rating on shares of Stryker in a report on Wednesday, October 8th. Rothschild Redb upgraded Stryker to a “hold” rating in a report on Thursday, September 18th. Finally, Needham & Company LLC boosted their target price on Stryker from $442.00 to $448.00 and gave the company a “buy” rating in a research note on Friday, August 1st. Fifteen analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. Based on data from MarketBeat.com, Stryker has a consensus rating of “Moderate Buy” and a consensus price target of $432.24.

Insider Activity at Stryker

In other Stryker news, Director Ronda E. Stryker sold 200,000 shares of the business’s stock in a transaction that occurred on Wednesday, August 6th. The stock was sold at an average price of $376.45, for a total transaction of $75,290,000.00. Following the transaction, the director owned 3,222,108 shares of the company’s stock, valued at $1,212,962,556.60. The trade was a 5.84% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Viju Menon sold 500 shares of the business’s stock in a transaction that occurred on Monday, August 25th. The stock was sold at an average price of $390.61, for a total value of $195,305.00. Following the transaction, the insider directly owned 12,511 shares in the company, valued at $4,886,921.71. This trade represents a 3.84% decrease in their position. The disclosure for this sale can be found here. 5.90% of the stock is owned by insiders.

Stryker Trading Up 2.1%

NYSE SYK opened at $387.84 on Thursday. The stock has a market capitalization of $148.27 billion, a price-to-earnings ratio of 51.37, a PEG ratio of 2.74 and a beta of 0.94. The stock’s 50 day moving average price is $379.74 and its two-hundred day moving average price is $379.16. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.06 and a current ratio of 1.78. Stryker Corporation has a 52 week low of $329.16 and a 52 week high of $406.19.

Stryker (NYSE:SYK) last released its earnings results on Thursday, July 31st. The medical technology company reported $3.13 EPS for the quarter, beating the consensus estimate of $3.07 by $0.06. The firm had revenue of $6.02 billion for the quarter, compared to analysts’ expectations of $5.92 billion. Stryker had a return on equity of 23.94% and a net margin of 12.25%.The business’s quarterly revenue was up 11.1% compared to the same quarter last year. During the same quarter in the previous year, the business posted $2.81 EPS. Stryker has set its FY 2025 guidance at 13.400-13.600 EPS. As a group, analysts anticipate that Stryker Corporation will post 13.47 earnings per share for the current fiscal year.

Stryker Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Tuesday, September 30th will be given a dividend of $0.84 per share. The ex-dividend date of this dividend is Tuesday, September 30th. This represents a $3.36 annualized dividend and a dividend yield of 0.9%. Stryker’s payout ratio is 44.50%.

Stryker Company Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.